{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:45:45Z","timestamp":1756385145731},"reference-count":15,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","diseaseamonth.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Disease-a-Month"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.disamonth.2015.08.005","type":"journal-article","created":{"date-parts":[[2015,9,12]],"date-time":"2015-09-12T11:53:32Z","timestamp":1442058812000},"page":"442-447","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Autosomal dominant polycystic kidney disease"],"prefix":"10.1016","volume":"61","author":[{"given":"Jonathan","family":"Silverman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaitanya","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar V.","family":"Lerma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.disamonth.2015.08.005_bib1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1056\/NEJM199307293290508","article-title":"Autosomal dominant polycystic kidney disease","volume":"329","author":"Gabow","year":"1993","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.disamonth.2015.08.005_bib2","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1681\/ASN.V491670","article-title":"Autosomal dominant polycystic kidney disease in blacks: clinical course and effects of sickle-cell hemoglobin","volume":"4","author":"Yium","year":"1994","journal-title":"J Am Soc Nephrol"},{"issue":"9147","key":"10.1016\/j.disamonth.2015.08.005_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(98)03495-3","article-title":"Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group","volume":"353","author":"Hateboer","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.disamonth.2015.08.005_bib4","doi-asserted-by":"crossref","unstructured":"The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. The European Polycystic Kidney Disease Consortium. Cell. 1994 Aug 26;78(4):725.","DOI":"10.1016\/0092-8674(94)90137-6"},{"issue":"6751","key":"10.1016\/j.disamonth.2015.08.005_bib5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/43907","article-title":"Polycystin-L is a calcium-regulated cation channel permeable to calcium ions","volume":"401","author":"Chen","year":"1999","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.disamonth.2015.08.005_bib6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/j.ackd.2010.01.002","article-title":"Molecular advances in autosomal dominant polycystic kidney disease","volume":"17","author":"Gallagher","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"issue":"25","key":"10.1016\/j.disamonth.2015.08.005_bib7","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.disamonth.2015.08.005_bib8","unstructured":"Torres VE, Harris PC. Autosomal dominant polycystic kidney disease. In: Johnson RJ, Feehally J, loege J, eds. Comprehensive clinical nephrology. 5th edn. Elsevier; 2015. p. 536\u2013548"},{"issue":"1","key":"10.1016\/j.disamonth.2015.08.005_bib9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2215\/CJN.00080605","article-title":"Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort","volume":"1","author":"Bae","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.disamonth.2015.08.005_bib10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0272-6386(12)80541-5","article-title":"Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease","volume":"20","author":"Gabow","year":"1992","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.disamonth.2015.08.005_bib11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0272-6386(12)80922-X","article-title":"Renal stone disease in autosomal dominant polycystic kidney disease","volume":"22","author":"Torres","year":"1993","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.disamonth.2015.08.005_bib12","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/ki.1994.354","article-title":"Hereditary and acquired cystic disease of the kidney","volume":"46","author":"Fick","year":"1994","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.disamonth.2015.08.005_bib13","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1681\/ASN.2008080882","article-title":"Renal volume, renin\u2013angiotensin\u2013aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease","volume":"20","author":"Schrier","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"9569","key":"10.1016\/j.disamonth.2015.08.005_bib14","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.disamonth.2015.08.005_bib15","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1053\/ajkd.2001.27720","article-title":"Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality","volume":"38","author":"Perrone","year":"2001","journal-title":"Am J Kidney Dis"}],"container-title":["Disease-a-Month"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001150291500108X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001150291500108X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T18:52:23Z","timestamp":1653159143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001150291500108X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S001150291500108X"],"URL":"https:\/\/doi.org\/10.1016\/j.disamonth.2015.08.005","relation":{},"ISSN":["0011-5029"],"issn-type":[{"value":"0011-5029","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autosomal dominant polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Disease-a-Month","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.disamonth.2015.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}